In T2D, glycemic control up with continuous glucose monitoring

In T2D, glycemic control up with continuous glucose monitoring

(HealthDay)—Adults with type 2 diabetes receiving multiple daily insulin injections randomized to continuous glucose monitoring (CGM) have improved glycemic control versus usual care, according to a study published online Aug. 22 in the Annals of Internal Medicine.

Roy W. Beck, M.D., Ph.D., from the Jaeb Center for Health Research in Tampa, Fla., and colleagues examined the effectiveness of CGM in adults with type 2 diabetes receiving multiple daily insulin injections. Data were included for 158 adults who had had type 2 diabetes for a median of 17 years. Participants were randomized to CGM or usual care (79 in each group).

The researchers found that at 24 weeks, the mean hemoglobin A1c levels decreased to 7.7 and 8.0 percent in the CGM and control groups, respectively (adjusted difference in mean change, −0.3 percent; 95 percent confidence interval, −0.5 to 0.0 percent; P = 0.022). CGM-measured hypoglycemia or quality-of-life outcomes did not differ meaningfully between the groups. The average CGM use per week was 6.7 days in the CGM group.

"A high percentage of who received multiple daily insulin injections for type 2 diabetes used CGM on a daily or near-daily basis for 24 weeks and had improved ," the authors write. "Because few insulin-treated patients with type 2 currently use CGM, these results support an additional management method that may benefit these patients."

Several authors disclosed financial ties to pharmaceutical companies, including Dexcom, which funded the study.


Explore further

Can continuous glucose monitoring improve diabetes control in patients with type 1 diabetes who inject insulin

More information: Abstract/Full Text (subscription or payment may be required)
Editorial (subscription or payment may be required)
Journal information: Annals of Internal Medicine

Copyright © 2017 HealthDay. All rights reserved.

Citation: In T2D, glycemic control up with continuous glucose monitoring (2017, August 23) retrieved 17 September 2019 from https://medicalxpress.com/news/2017-08-t2d-glycemic-glucose.html
This document is subject to copyright. Apart from any fair dealing for the purpose of private study or research, no part may be reproduced without the written permission. The content is provided for information purposes only.
0 shares

Feedback to editors

User comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more